Please login to the form below

Not currently logged in
Email:
Password:

elvitegravir

This page shows the latest elvitegravir news and features for those working in and with pharma, biotech and healthcare.

Gilead plans fightback against HIV arch-rival ViiV

Gilead plans fightback against HIV arch-rival ViiV

The strong uptake of ViiV's drugs comes on the back of what is viewed as a superior profile for dolutegravir compared to Gilead's current integrase inhibitor elvitegravir - found in

Latest news

More from news
Approximately 4 fully matching, plus 32 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Complete Medical Communications (CMC)

CMC is a leading global agency dedicated to healthcare communications across the lifecycle. We combine scientific acumen, excellence in delivery...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics